SEARCH

SEARCH BY CITATION

References

  • Aledo J. C., Gomez-Fabre P. M., Olalla L. and Marquez J. (2000) Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm. Genome 11, 11071110.
  • Belanich M., Pastor M., Randall T. et al. (1996) Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res. 56, 783788.
  • Biswas T., Ramana C. V., Srinivasan G., Boldogh I., Hazra T. K., Chen Z., Tano K., Thompson E. B. and Mitra S. (1999) Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene 18, 525532.
  • Bobola M. S., Silber J. R., Ellenbogen R. G., Geyer J. R., Blank A. and Goff R. D. (2005) O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin. Cancer Res. 11, 27472755.
  • Bocangel D., Sengupta S., Mitra S. and Bhakat K. K. (2009) p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. Anticancer Res. 29, 37413750.
  • Boldogh I., Ramana C. V., Chen Z., Biswas T., Hazra T. K., Grösch S., Grombacher T., Mitra S. and Kaina B. (1998) Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res. 58, 39503956.
  • Brasse-Lagnel C., Lavoinne A. and Husson A. (2009) Control of mammalian gene expression by amino acids, especially glutamine. FEBS J. 276, 18261844.
  • Christmann M., Nagel G., Horn S., Krahn U., Wiewrodt D., Sommer C. and Kaina B. (2010) MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma. Int. J. Cancer 127, 21062118.
  • Costello J. F., Futscher B. W., Kroes R. A. and Pieper R. O. (1994) Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14, 65156521.
  • Curthoys N. P. and Watford M. (1995) Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15, 133159.
  • DeBerardinis R. J. and Cheng T. (2010) Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29, 313324.
  • Elgadi K. M., Meguid R. A., Qian M., Souba W. W. and Abcouwer S. F. (1999) Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol. Genomics 1, 5162.
  • Esteller M., Garcia-Foncillas J., Andion E., Goodman S. N., Hidalgo O. F., Vanaclocha V., Baylin S. B. and Herman J. G. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343, 13501354.
  • Fruehauf J. P., Brem H., Brem S., Sloan A., Barger G., Huang W. and Parker R. (2006) In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin. Cancer Res. 12, 45234532.
  • Gomez-Fabre P. M., Aledo J. C., Del Castillo-Olivares A., Alonso F. J., Nunez De Castro I., Campos J. A. and Marquez J. (2000) Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem. J. 345, 365375.
  • Harris L. C., Potter P. M., Tano K., Shiota S., Mitra S. and Brent T. P. (1991) Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res. 19, 61636167.
  • Hegi M. E., Diserens A. C., Gorlia T. et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 9971003.
  • Hermisson M., Klumpp A., Wick W., Wischhusen J., Nagel G., Roos W., Kaina B. and Weller M. (2006) O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J. Neurochem. 96, 766776.
  • Hu W., Zhang C., Wu R., Sun Y., Levine A. and Feng Z. (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl Acad. Sci. USA 107, 74557460.
  • Jacinto F. V. and Esteller M. (2007) MGMT hypermethylation: a prognostic foe, a predictive friend. DNA Repair (Amst) 6, 11551160.
  • Jaeckle K. A., Eyre H. J., Townsend J. J., Schulman S., Knudson H. M., Belanich M., Yarosh D. B., Bearman S. I., Giroux D. J. and Schold S. C. (1998) Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J. Clin. Oncol. 16, 33103315.
  • Kaina B., Christmann M., Naumann S. and Roos W. P. (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity an apoptosis induced by alkylating agents. DNA Repair (Amst) 6, 10791099.
  • Kanzawa T., Bedwell J., Kondo Y., Kondo S. and Germano I. M. (2003) Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J. Neurosurg. 99, 10471052.
  • Katoh M. and Katoh M. (2007) WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13, 40424045.
  • Kitange G. J., Carlson B. L., Schroeder M. A., Grogan P. T., Lamont J. D., Decker P. A., Wu W., James C. D. and Sarkania J. N. (2009) Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro Oncol. 11, 281291.
  • Kokkinakis D. M., Bocangel D. B., Schold S. C., Moschel R. C. and Pegg A. E. (2001) Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Clin. Cancer Res. 7, 421428.
  • Lavon I., Fuchs D., Zrihan D., Efroni G., Zelikovitch B., Fellig Y. and Siegal T. (2007) Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase. Cancer Res. 67, 89528959.
  • Lechapt-Zalcman E., Levallet G., Dugué A. E. et al. (2012) O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. Cancer. doi: 10.1002/cncr.27441.
  • Lefranc F., Facchini V. and Kiss R. (2007) Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12, 13951403.
  • Marquez J., de la Oliva A. R., Mates J. M., Segura J. A. and Alonso F. J. (2006) Glutaminase: a multifaceted protein not only involved in generating glutamate. Neurochem. Int. 8, 465471.
  • Van Meir E. G., Kikuchi T., Tada M., Li H., Diserens A. C., Wojcik B. E., Huang H. J., Friedmann T., de Tribolet N. and Cavenee W. K. (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649652.
  • Mineura K., Izumi I., Watanabe K. and Kowada M. (1993) Influence of O6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain tumors. Int. J. Cancer 55, 7681.
  • Nagane M., Asai A., Shibui S., Nomura K. and Kuchino Y. (1997) Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas. Neurosurgery 41, 434441.
  • Nagane M., Kobayashi K., Ohnishi A., Shimizu S. and Shiokawa Y. (2007) Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide. Jpn. J. Clin. Oncol. 37, 897906.
  • Olalla L., Aledo J. C., Bannenberg G. and Marquez J. (2001) The C-terminus of human glutaminase L mediates association with PDZ domain-containing proteins. FEBS Lett. 488, 116122.
  • Olalla L., Gutierrez A., Campos J. A., Khan Z. U., Alonso F. J., Segura J. A., Marquez J. and Aledo J. C. (2002) Nuclear localization of L-type glutaminase in mammalian brain. J. Biol. Chem. 277, 3893938944.
  • Pegg A. E., Dolan M. E. and Moschel R. C. (1995) Structure, function and inhibition of O6-alkylguanine-DNA-alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 51, 167223.
  • La Porta C. A. and Comolli R. (1998) PKC-dependent modulation of IkB alpha-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res. 18, 25912597.
  • Roos W. P., Batista L. F., Naumann S. C., Wick W., Weller M., Menck C. F. and Kaina B. (2007) Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26, 186197.
  • Szeliga M. and Obara-Michlewska M. (2009) Glutamine in neoplastic cells: focus on the expression and roles of glutaminases. Neurochem. Int. 55, 7175.
  • Szeliga M., Sidoryk M., Matyja E., Kowalczyk P. and Albrecht J. (2005) Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci. Lett. 374, 171173.
  • Szeliga M., Matyja E., Obara M., Grajkowska W., Czernicki T. and Albrecht J. (2008) Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem. Res. 33, 808813.
  • Szeliga M., Obara-Michlewska M., Matyja E., Łazarczyk M., Lobo C., Hilgier W., Alonso F. J., Marquez J. and Albrecht J. (2009) Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells. Glia 57, 10141023.
  • Ueda S., Mineta T., Nakahara Y., Okamoto H., Shiraishi T. and Tabuchi K. (2004) Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J. Neurosurg. 101, 659663.
  • Wiewrodt D., Nagel G., Dreimüller N., Hundsberger T., Perneczky A. and Kaina B. (2008) MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome. Int. J. Cancer 122, 13911399.
  • Yoshino A., Ogino A., Yachi K., Ohta T., Fukushima T., Watanabe T., Katayama Y., Okamoto Y., Narusz N. and Sano E. (2009) Effect of IFN-b on human glioma cell lines with temozolomide resistance. Int. J. Oncol. 35, 139148.